A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.

The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened." The group, speaking ...